1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. Key Offerings
1.2. Market Segmentation
1.3. Research Methodology
1.3.1. Phase I - Secondary Research
1.3.2. Phase II - Primary Research
1.3.3. Phase III - Expert Panel Review
1.3.4. Assumptions
1.3.5. Approach Adopted

2. Executive Summary
2.1. Market Snapshot: Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market
2.3. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market, By Therapy, 2025 (US$ Million)
2.4. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market, By Geography, 2025 (US$ Million)
2.5. Attractive Investment Proposition by Geography, 2025

3. Hypoactive Sexual Desire Disorder (HSDD) Treatment Market: Competitive Analysis
3.1. Market Positioning of Key Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Vendors
3.2. Strategies Adopted by Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Vendors

4. Hypoactive Sexual Desire Disorder (HSDD) Treatment Market: Macro Analysis & Market Dynamics
4.1. Introduction
4.2. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Value, 2024 - 2034, (US$ Million)
4.3. Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Key Challenges
4.3.4. Key Opportunities
4.4. Impact Analysis of Drivers and Restraints
4.5. Porter's Five Force Model
4.5.1. Supplier Power
4.5.2. Buyer Power
4.5.3. Threat Of Substitutes
4.5.4. Threat Of New Entrants
4.5.5. Competitive Rivalry
4.6. PESTEL Analysis
4.6.1. Political Landscape
4.6.2. Economic Landscape
4.6.3. Social Landscape
4.6.4. Technology Landscape
4.6.5. Environmental Landscape
4.6.6. Legal Landscape

5. Hypoactive Sexual Desire Disorder (HSDD) Treatment Market: By Therapy, 2024-2034, USD (Million)
5.1. Market Overview
5.2. Growth & Revenue Analysis: 2025 Versus 2034
5.3. Market Segmentation
5.3.1. Buspirone
5.3.2. Bupropion
5.3.3. Testosterone
5.3.4. Flibanserin
5.3.5. Bremelanotide
5.3.6. Cognitive Behavior Therapy
5.3.7. Pipeline Analysis
5.3.7.1. Phase III Drug
5.3.7.1.1. Prasterone 6.5 mg Vaginal Insert
5.3.7.1.2. BP101

6. North America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market, 2024-2034, USD (Million)
6.1. Market Overview
6.2. Hypoactive Sexual Desire Disorder (HSDD) Treatment Market: By Therapy, 2024-2034, USD (Million)
6.3. Hypoactive Sexual Desire Disorder (HSDD) Treatment Market: By Region, 2024-2034, USD (Million)
6.3.1.North America
6.3.1.1. U.S.
6.3.1.1.1. Hypoactive Sexual Desire Disorder (HSDD) Treatment Market: By Therapy, 2024-2034, USD (Million)
6.3.1.2. Canada
6.3.1.2.1. Hypoactive Sexual Desire Disorder (HSDD) Treatment Market: By Therapy, 2024-2034, USD (Million)
6.3.1.3. Rest of North America
6.3.1.3.1. Hypoactive Sexual Desire Disorder (HSDD) Treatment Market: By Therapy, 2024-2034, USD (Million)

7. UK and European Union Hypoactive Sexual Desire Disorder (HSDD) Treatment Market, 2024-2034, USD (Million)
7.1. Market Overview
7.2. Hypoactive Sexual Desire Disorder (HSDD) Treatment Market: By Therapy, 2024-2034, USD (Million)
7.3. Hypoactive Sexual Desire Disorder (HSDD) Treatment Market: By Region, 2024-2034, USD (Million)
7.3.1.UK and European Union
7.3.1.1. UK
7.3.1.1.1. Hypoactive Sexual Desire Disorder (HSDD) Treatment Market: By Therapy, 2024-2034, USD (Million)
7.3.1.2. Germany
7.3.1.2.1. Hypoactive Sexual Desire Disorder (HSDD) Treatment Market: By Therapy, 2024-2034, USD (Million)
7.3.1.3. Spain
7.3.1.3.1. Hypoactive Sexual Desire Disorder (HSDD) Treatment Market: By Therapy, 2024-2034, USD (Million)
7.3.1.4. Italy
7.3.1.4.1. Hypoactive Sexual Desire Disorder (HSDD) Treatment Market: By Therapy, 2024-2034, USD (Million)
7.3.1.5. France
7.3.1.5.1. Hypoactive Sexual Desire Disorder (HSDD) Treatment Market: By Therapy, 2024-2034, USD (Million)
7.3.1.6. Rest of Europe
7.3.1.6.1. Hypoactive Sexual Desire Disorder (HSDD) Treatment Market: By Therapy, 2024-2034, USD (Million)

8. Asia Pacific Hypoactive Sexual Desire Disorder (HSDD) Treatment Market, 2024-2034, USD (Million)
8.1. Market Overview
8.2. Hypoactive Sexual Desire Disorder (HSDD) Treatment Market: By Therapy, 2024-2034, USD (Million)
8.3. Hypoactive Sexual Desire Disorder (HSDD) Treatment Market: By Region, 2024-2034, USD (Million)
8.3.1.Asia Pacific
8.3.1.1. China
8.3.1.1.1. Hypoactive Sexual Desire Disorder (HSDD) Treatment Market: By Therapy, 2024-2034, USD (Million)
8.3.1.2. Japan
8.3.1.2.1. Hypoactive Sexual Desire Disorder (HSDD) Treatment Market: By Therapy, 2024-2034, USD (Million)
8.3.1.3. India
8.3.1.3.1. Hypoactive Sexual Desire Disorder (HSDD) Treatment Market: By Therapy, 2024-2034, USD (Million)
8.3.1.4. Australia
8.3.1.4.1. Hypoactive Sexual Desire Disorder (HSDD) Treatment Market: By Therapy, 2024-2034, USD (Million)
8.3.1.5. South Korea
8.3.1.5.1. Hypoactive Sexual Desire Disorder (HSDD) Treatment Market: By Therapy, 2024-2034, USD (Million)
8.3.1.6. Rest of Asia Pacific
8.3.1.6.1. Hypoactive Sexual Desire Disorder (HSDD) Treatment Market: By Therapy, 2024-2034, USD (Million)

9. Latin America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market, 2024-2034, USD (Million)
9.1. Market Overview
9.2. Hypoactive Sexual Desire Disorder (HSDD) Treatment Market: By Therapy, 2024-2034, USD (Million)
9.3. Hypoactive Sexual Desire Disorder (HSDD) Treatment Market: By Region, 2024-2034, USD (Million)
9.3.1.Latin America
9.3.1.1. Brazil
9.3.1.1.1. Hypoactive Sexual Desire Disorder (HSDD) Treatment Market: By Therapy, 2024-2034, USD (Million)
9.3.1.2. Mexico
9.3.1.2.1. Hypoactive Sexual Desire Disorder (HSDD) Treatment Market: By Therapy, 2024-2034, USD (Million)
9.3.1.3. Rest of Latin America
9.3.1.3.1. Hypoactive Sexual Desire Disorder (HSDD) Treatment Market: By Therapy, 2024-2034, USD (Million)

10. Middle East and Africa Hypoactive Sexual Desire Disorder (HSDD) Treatment Market, 2024-2034, USD (Million)
10.1. Market Overview
10.2. Hypoactive Sexual Desire Disorder (HSDD) Treatment Market: By Therapy, 2024-2034, USD (Million)
10.3. Hypoactive Sexual Desire Disorder (HSDD) Treatment Market: By Region, 2024-2034, USD (Million)
10.3.1.Middle East and Africa
10.3.1.1. GCC
10.3.1.1.1. Hypoactive Sexual Desire Disorder (HSDD) Treatment Market: By Therapy, 2024-2034, USD (Million)
10.3.1.2. Africa
10.3.1.2.1. Hypoactive Sexual Desire Disorder (HSDD) Treatment Market: By Therapy, 2024-2034, USD (Million)
10.3.1.3. Rest of Middle East and Africa
10.3.1.3.1. Hypoactive Sexual Desire Disorder (HSDD) Treatment Market: By Therapy, 2024-2034, USD (Million)

11. Company Profile
11.1. AMAG Pharmaceuticals (Company Overview, Financial Performance, Product Portfolio, Strategic Initiatives)
11.2. Allergan, Plc.
11.3. Ivix LLX
11.4. EndoCeutics, Inc.
11.5. Emotional Brain BV
11.6. S1 Biopharma, Inc.
11.7. Sprout Pharmaceuticals, Inc.